SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-18-005234
Filing Date
2018-07-27
Accepted
2018-07-27 07:43:27
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 a2236329z424b5.htm 424B5 795335
2 G393885.JPG g393885.jpg GRAPHIC 14542
3 G340219.JPG g340219.jpg GRAPHIC 1330
4 G867892.JPG g867892.jpg GRAPHIC 160869
5 G788960.JPG g788960.jpg GRAPHIC 21824
6 G413503.JPG g413503.jpg GRAPHIC 15691
7 G213688.JPG g213688.jpg GRAPHIC 1340
  Complete submission text file 0001047469-18-005234.txt   1094222
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-218301 | Film No.: 18973260
SIC: 2834 Pharmaceutical Preparations